- Scheele Symposium 2013 update: Check out the speakers at the 2013 Scheele Symposium on November 13 under ”Scheele Symposium” above.
- The 2013 Scheele award to Professor Garret A FitzGerald
“for his translational approach to elucidating the mechanisms of drug action and his substantial contribution to the development of low dose aspirin as a strategy for the prevention and treatment of cardiovascular disease and stroke. Professor FitzGerald was the first to predict and explain the cardiovascular hazard from non- steroidal anti-inflammatory drugs (NSAIDs,) including those selective for COX-2, establishing a new paradigm for our approach to drug safety. Aside from these contributions, Professor FitzGerald has also made discoveries fundamental to our understanding of how central and peripheral clocks interact and how dysfunction of peripheral clocks can influence predisposition to cardiometabolic disease”